Clik here to view.
Is Anonymization Possible with Current Technologies?
On December 11, 2018, Rebecca Herold, ‘The Privacy Professor’ hosted Privacy Analytics CEO Dr. Khaled Emam for an on-demand podcast about data privacy and the impact of new technologies, including...
View ArticleClik here to view.
“Zero Risk Does Not Exist”
Privacy Rights in the Digital Era was the headline theme for this event. The Institute for Humane Studies co-sponsored the event with the Program on Economics & Privacy at George Mason...
View ArticleVideo: How to Safely Share Clinical Trial Data Today
Watch Dr. Khaled El Emam’s webcast presentation from Clinical Trial Data Sharing Forum 2019 in Tokyo. You’ll learn: – The critical differences between expert determination and Safe Harbor; – Why...
View ArticleClik here to view.
Advancing Principled Data Practices in Support of Emerging Technologies
Interview with Jules Polonetsky, Chief Executive Officer, Future of Privacy Forum “I’m an optimist when it comes to data,” Jules Polonetsky declares with the candor one expects from a native New...
View ArticleWebcast: Escape From The Data Swamp
Escape from the Data Swamp Data velocity and privacy concerns are colliding. Data lakes are turning into data swamps. What’s next? Check out this webcast with world-renowned data gurus Jules Polonetsky...
View ArticleClik here to view.
Maximizing Data Value with Full GDPR and HIPAA Compliance through Anonymization
How to solve the privacy dilemma and get the win-win If your organization is focused on maximizing data value, while also protecting data as a core asset, you may be on the horns of a privacy dilemma....
View ArticleClik here to view.
GDPR and The Future of Clinical Trials Data Sharing
How will GDPR continue to impact the future of Clinical Trials Data Sharing? Insights from Privacy Analytics’ Executive Roundtable Event: Privacy Analytics’ Executive Round Table on the Future of...
View ArticlePrivacy Analytics Events 2019
If you’re looking to safely turn your most sensitive data assets into your most powerful business drivers then you’ll be interested in the events schedule below. Our privacy experts are speaking across...
View ArticleClik here to view.
Early Impact of Health Canada’s New Guidelines
Sarah Lyons – Senior Director, Operations Health Canada has introduced new regulatory guidance for anonymizing clinical study reports. As background, Bill C-17 Protecting Canadians from Unsafe Drugs...
View ArticleClik here to view.
Learning at Scale: Anonymizing Unstructured Data using AI/ML
by Rachel Li, Ph.D. – Senior Machine Learning Engineer Unstructured data, such as medical notes, pose unique challenges with regards to anonymization. Not having a traditional database means that you...
View ArticleDeep-Diving into Re-identification: Perspectives On An Article In Nature...
by Dr. Khaled El-Emam – General Manager of Privacy Analytics Recently, an article in Nature Communications caught our attention, primarily because it discussed re-identification risk. It also happened...
View ArticleWhen to Integrate Anonymization of Documents and Data
by Sarah Lyons – Senior Director, Operations Should sponsors integrate risk-based anonymization across both documents and structured individual patient data (S-IPD)? Good question—and a common one. The...
View ArticleCan you comply your way to greatness?
by Sarah Lyons – Senior Director, Operations I recently heard something that stuck with me: “Nobody complies their way to greatness.” An interesting comment, and a relevant one for all of us in the...
View ArticleClik here to view.
Turn Data Assets into Business Opportunity Under CCPA
by Luk Arbuckle – Chief Methodologist Business Problem How the CCPA is changing the legislative landscape Since the California Consumer Privacy Act was signed in 2018, multiple other states have...
View ArticleClik here to view.
What do I need to know about transitioning from Safe Harbor to Expert...
Switching de-identification methods might be the most valuable data decision your company can make. In this video, Luk Arbuckle, Privacy Analytics’ Chief Methodologist, covers the basics of switching....
View ArticleClik here to view.
What is HIPAA de-identification?
The HIPAA Privacy Rule outlines specific ways to de-identify Protected Health Information (PHI). In this video, Luk Arbuckle, Privacy Analytics’ Chief Methodologist, breaks down the specifics to help...
View ArticleClik here to view.
What is the difference between data masking, de-identification, and...
These terms come up often in discussions about data privacy, but their definitions are sometimes unclear. In this video, Grant Middleton, Privacy Analytics’ Senior Solutions Architect, explains what...
View ArticleClik here to view.
How can we safely gain business value from sensitive data?
Sarah Lyons, Privacy Analytics’ General Manager, on safely gaining business value from your sensitive data. The post How can we safely gain business value from sensitive data? appeared first on...
View ArticleClik here to view.
Should we invest in building our own de-identification capability?
Watch our De-Identification Services Business Leader, Grant Middleton, answer the question: “Should we invest in building internal de-identification capability?” The post Should we invest in building...
View ArticleClik here to view.
What do I need to know about GDPR, HIPAA and CCPA to meet our regulatory and...
Depending on where you’re based, and where you do business, your data requires certain levels of regulatory compliance. In this video, Luk Arbuckle, Privacy Analytics’ Chief Methodologist, explains...
View Article